CrownPeak Helps Pharmaceutical/Biotech Client CV
Therapeutics Manage and Distribute Content
LOS ANGELES, CA. May 6, 2008 – CrownPeak, the company
defining the future of content management, today announced that CV Therapeutics,
Inc. has implemented CrownPeak’s award-winning content management system (CMS)
to manage three of the company’s web sites. CV Therapeutics, a biopharmaceutical
company primarily focused on the discovery, development and commercialization of
new small molecule drugs for the treatment of cardiovascular diseases,
represents CrownPeak’s first client in the pharmaceutical or biotech
industry.
The CrownPeak CMS has enabled internal stakeholders at CV
Therapeutics to update general company, R&D, investor and career information
on the corporate web site www.cvt.com. The CMS
is also being utilized to manage information on www.Ranexa.com for the company’s premiere
product Ranexa® (ranolazine extended-release tablets), the first new
pharmaceutical approach to treat chronic angina in the United
States in more than 20 years.
“Being able to communicate accurate information with our
various stakeholders in a timely fashion is absolutely critical in our
industry,” says Tina Sampath, Associate Director of eMarketing for CV
Therapeutics. “Prior to implementing the CrownPeak CMS, we were completely
reliant upon a third party web agency.
Now with CrownPeak, we have complete control of the update process for
our websites.
In addition to implementing the actual content management
system, CrownPeak manages web hosting and web analytics for CV Therapeutics.
“With the understanding that timely dissemination of accurate
information is very importance in their field, our aim was to tailor the control
of each web site to match the goal of their particular audience,” says Jim
Howard, chief executive officer of CrownPeak. “We are honored that a
distinguished pharmaceutical firm such as CV Therapeutics would entrust the
entire management of their content systems to us. We look forward to building
out new features that will continue to make it easier for CV Therapeutics to
communicate with their various audiences.”
About CrownPeak
CrownPeak is the market leader in providing on-demand web site software. CrownPeak’s unique combination of software
and services give Web site managers complete control over the critical functions
involved in delivering a successful, revenue-driving Web site.
Hundreds of diverse organizations such as 3M, Hyundai Motors,
Home Depot, EMI Music, the State of Virginia and the National Institutes of Health
have realized the value in CrownPeak’s software’s renowned ease-of-use, and its
24x7 customer support and guaranteed response times. CrownPeak’s
ContentManagement.com also provides easy to use and cost-effective content management solutions for smaller and
mid-sized organizations. CrownPeak has been named to EContent’s 100 most
influential companies list, has won eWeek’s prestigious Analysts Choice Award
and InfoWorld’s Product of the Year Award and has been named a finalist for Best
Customer Service from the American Business "Stevie" Awards for the last two
years.
About CV Therapeutics
CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company
primarily focused on applying molecular cardiology to the discovery, development
and commercialization of novel, small molecule drugs for the treatment of
cardiovascular diseases.
CV
Therapeutics' approved products include Ranexa® (ranolazine extended-release
tablets), indicated for the treatment of chronic angina in patients who have not
achieved an adequate response with other antianginal drugs, and Lexiscan™
(regadenoson) injection for use as a pharmacologic stress agent in radionuclide
myocardial perfusion imaging in patients unable to undergo adequate exercise
stress.
Media Contact:
Edward Yang
edward@firecrackerpr.com,
(949)
500-6422
www.firecrackerpr.com
